Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Stoke Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −2 vs. Q2 2023
- Shares held
- 43.8M
- −2.72M (−5.8%) vs. Q2 2023
- Total value
- $173.1M
- −$321.6M (−65.0%) vs. Q2 2023
- New holders
- 17
- 25 more added
- Sold out
- 19
- 36 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $2.49B |
| Q1 2026 | 198 | $2.31B |
| Q4 2025 | 183 | $2.13B |
| Q3 2025 | 151 | $1.57B |
| Q2 2025 | 134 | $744.0M |
| Q1 2025 | 126 | $421.6M |
| Q4 2024 | 130 | $640.4M |
| Q3 2024 | 118 | $715.5M |
| Q2 2024 | 115 | $828.5M |
| Q1 2024 | 103 | $731.7M |
| Q4 2023 | 81 | $236.9M |
| Q3 2023 | 97 | $173.1M |
| Q2 2023 | 100 | $494.8M |
| Q1 2023 | 97 | $371.8M |
| Q4 2022 | 107 | $371.8M |
| Q3 2022 | 105 | $544.4M |
| Q2 2022 | 92 | $569.4M |
| Q1 2022 | 99 | $870.6M |
| Q4 2021 | 94 | $849.6M |
| Q3 2021 | 90 | $492.4M |
| Q2 2021 | 97 | $680.3M |
| Q1 2021 | 106 | $1.49B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Stoke Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −102,489−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −62,902−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −45,575−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −42,300−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −26,186−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −24,700−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −23,592−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −15,783−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,180−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −12,643−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,382−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −1,031−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −412−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Endurance Wealth Management, Inc. | – | – | – | – | Not filed |